Illumina, Inc.
ILMNNASDAQHealthcare● Active
$162.78
+$0.46(+0.28%)
Market Cap$24.6B
P/E Ratio—
52W High$172.49
52W Low$81.76
Illumina, Inc. (ILMN) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
ILMN · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: Apr 30, 2026EPS Actual
$1.15
Est. $1.05 · +9.5%
Revenue
$1.09B
Est. $1.07B · +1.7%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
Apr 30, 2026
After Market Close
▲ Beat EPS▲ Beat Revenue🔥 5-Quarter EPS Beat Streak
ILMN reports quarterly as a NASDAQ-listed Medical - Diagnostics & Research company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$0.07
Rev. $15.39B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$0.07
Rev. Est.$15.39B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Jul 30, 2026 | $1.24 | — | — | — | $1.13B | — |
| ▲ Q2 FY2026 | Apr 30, 2026 | $1.05 | $1.15 | +9.5% | $1.09B | $1.07B | +1.7% |
| ▲ Q1 FY2026 | Feb 5, 2026 | $1.24 | $1.35 | +8.9% | $1.16B | $1.12B | +3.6% |
| ▲ Q4 FY2025 | Oct 30, 2025 | $1.17 | $1.34 | +14.5% | $1.08B | $1.07B | +1.6% |
| ▲ Q3 FY2025 | Jul 31, 2025 | $1.02 | $1.19 | +16.7% | $1.06B | $1.06B | -0.6% |
| ▲ Q2 FY2025 | May 8, 2025 | $0.94 | $0.97 | +3.2% | $1.04B | $1.03B | +1.5% |
| ▼ Q1 FY2025 | Feb 6, 2025 | $0.92 | $0.86 | -6.5% | $1.10B | $1.07B | +3.0% |
| ▲ Q4 FY2024 | Nov 4, 2024 | $0.88 | $1.14 | +29.7% | $1.08B | $1.08B | +0.0% |
Q3 FY2026
Jul 30, 2026
EPS Actual
—
EPS Est.
$1.24
EPS Surpr.
—
Revenue
—
Q2 FY2026
Apr 30, 2026Beat
EPS Actual
$1.15
EPS Est.
$1.05
EPS Surpr.
+9.5%
Revenue
$1.09B
Q1 FY2026
Feb 5, 2026Beat
EPS Actual
$1.35
EPS Est.
$1.24
EPS Surpr.
+8.9%
Revenue
$1.16B
Q4 FY2025
Oct 30, 2025Beat
EPS Actual
$1.34
EPS Est.
$1.17
EPS Surpr.
+14.5%
Revenue
$1.08B
Q3 FY2025
Jul 31, 2025Beat
EPS Actual
$1.19
EPS Est.
$1.02
EPS Surpr.
+16.7%
Revenue
$1.06B
Q2 FY2025
May 8, 2025Beat
EPS Actual
$0.97
EPS Est.
$0.94
EPS Surpr.
+3.2%
Revenue
$1.04B
Q1 FY2025
Feb 6, 2025Miss
EPS Actual
$0.86
EPS Est.
$0.92
EPS Surpr.
-6.5%
Revenue
$1.10B
Q4 FY2024
Nov 4, 2024Beat
EPS Actual
$1.14
EPS Est.
$0.88
EPS Surpr.
+29.7%
Revenue
$1.08B
Analyst Estimates
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2028 | $1.87 | $1.91 | $1.93 | 9 |
| Q3 FY2028 | $1.74 | $1.78 | $1.80 | 9 |
| Q2 FY2028 | $1.61 | $1.65 | $1.67 | 9 |
| Q1 FY2028 | $1.40 | $1.44 | $1.45 | 9 |
| Q4 FY2027 | $1.63 | $1.67 | $1.69 | 8 |
| Q3 FY2027 | $1.51 | $1.55 | $1.56 | 8 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2028 | $1.4B | $1.4B | $1.4B | 7 |
| Q3 FY2028 | $1.3B | $1.3B | $1.3B | 4 |
| Q2 FY2028 | $1.2B | $1.3B | $1.3B | 3 |
| Q1 FY2028 | $1.2B | $1.2B | $1.2B | 7 |
| Q4 FY2027 | $1.3B | $1.3B | $1.3B | 7 |
| Q3 FY2027 | $1.2B | $1.2B | $1.2B | 4 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q2 FY2026 | Apr 30, 2026 | +9.5% | $120.37 | $126.74 | +5.29% |
| ▲ Q1 FY2026 | Feb 5, 2026 | +8.9% | $134.19 | $133.61 | -0.43% |
| ▲ Q4 FY2025 | Oct 30, 2025 | +14.5% | $95.03 | $99.01 | +4.19% |
| ▲ Q3 FY2025 | Jul 31, 2025 | +16.7% | $106.66 | $102.71 | -3.70% |
| ▲ Q2 FY2025 | May 8, 2025 | +3.2% | $76.35 | $79.58 | +4.23% |
| ▼ Q1 FY2025 | Feb 6, 2025 | -6.5% | $124.68 | $122.80 | -1.51% |
| ▲ Q4 FY2024 | Nov 4, 2024 | +29.7% | $149.76 | $153.49 | +2.49% |
| ▲ Q3 FY2024 | Aug 6, 2024 | +228.5% | $115.47 | $116.36 | +0.77% |
Q2 FY2026+5.29%
Report Date
Apr 30, 2026
EPS Beat/Miss
+9.5%
Price Before
$120.37
Price After
$126.74
Q1 FY2026-0.43%
Report Date
Feb 5, 2026
EPS Beat/Miss
+8.9%
Price Before
$134.19
Price After
$133.61
Q4 FY2025+4.19%
Report Date
Oct 30, 2025
EPS Beat/Miss
+14.5%
Price Before
$95.03
Price After
$99.01
Q3 FY2025-3.70%
Report Date
Jul 31, 2025
EPS Beat/Miss
+16.7%
Price Before
$106.66
Price After
$102.71
Q2 FY2025+4.23%
Report Date
May 8, 2025
EPS Beat/Miss
+3.2%
Price Before
$76.35
Price After
$79.58
Q1 FY2025-1.51%
Report Date
Feb 6, 2025
EPS Beat/Miss
-6.5%
Price Before
$124.68
Price After
$122.80
Q4 FY2024+2.49%
Report Date
Nov 4, 2024
EPS Beat/Miss
+29.7%
Price Before
$149.76
Price After
$153.49
Q3 FY2024+0.77%
Report Date
Aug 6, 2024
EPS Beat/Miss
+228.5%
Price Before
$115.47
Price After
$116.36
Avg Beat Reaction+1.83%
Avg Miss Reaction-1.51%
Beat Rate7 / 8 quarters
Largest Move+5.29% (Q2 FY2026)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: ILMN ends December
Illumina, Inc. (ILMN) most recently reported earnings on April 30, 2026 for Q2 FY2026, posting EPS of $1.15 — beating the analyst consensus of $1.05 by +9.5%. ILMN has beaten EPS estimates for 5 consecutive quarters. The next ILMN earnings date is expected around September 1, 2026.
Each quarter, investors track ILMN earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. ILMN revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
ILMN's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
ILMN earnings · 5 questionsIllumina, Inc.'s next earnings report is expected around September 1, 2026. ILMN typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; ILMN historically reports after market close (AMC).
ILMN earnings datewhen is ILMN earningsILMN next earnings datewhen does ILMN report earningsILMN earnings calendar
▸ Source: FMP · Illumina, Inc. SEC filings · US GAAP · Illumina, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026